SBS - The best value in QMS software

PMCF plan to justify that our product not require PMCF study

#1
Hi all,

I am new to the field.
We have a class IIa product, and we have some questions when drafting a PMCF (post-market clinical follow-up study for CE Marking) plan and report.
We would like to justify that our product not require to have PMCF study.

Do the items listed on MEDDEV 2.12/2 rev2, "Part 5. Circumstances where a PMCF study is indicated" already enough to justify?
What's more information that we can stuff in to the plan and report?
Shall we also add literature search (which same with in CER) into our PMCF plan and report?

Please kindly advise, Thank you.
 
Elsmar Forum Sponsor

yodon

Staff member
Super Moderator
#2
This is a tough one, but I don't want to see it orphaned. :) We're all seemingly groping in the dark and stances by Tech File reviewers is somewhat all over the map.

I've had clients take what's in Part 5, make a checklist, and when all answers were 'no' (with justification), the reviewer accepted that a PMCF study was not required. Even if some answers were 'yes,' if there was adequate justification (and it had to be quite detailed), the reviewers agreed a study was not necessary.

I think you only need a Plan if a study is indicated. What we've done is say in the PMS Plan how we go about determining whether a PMCF study is necessary or not (the checklist). And if no study, no report.

Please don't take this as any guarantee! While it's worked a couple of times, like I said, reviewers are being VERY critical these days and getting more and more demanding of data supporting safety and efficacy. But if, truly, a study is NOT indicated, you SHOULD be able to justify not doing one. Just be prepared to back the assertion with good, um, data.
 

Watchcat

Trusted Information Resource
#3
I would disagree with the reviewers who accepted the checklist. I would look to the first sentence in Part 5 as my guide:

"...the decision to conduct PMCF studies must be based on the identification of possible residual risks and/or unclarity on long term clinical performance that may impact the benefit/risk ratio."

The central question is whether the data you already have are adequate to address risks, or whether you need to collect more. (I know, I know...you might be inclined to think that, if your data are not adequate, you shouldn't be getting a CE Mark in the first place. Don't be silly. This would stifle innovation.)

The checklist just gives examples of circumstances in which your data might not be adequate. It does not list all such circumstances, and much more important, no matter what circumstances you find yourself in, it does not tell you how to figure out whether your data are adequate or not.

Lucky for many companies I'm not a reviewer. Meow.
 
Last edited:

Weeder

Involved In Discussions
#4
I think one of the things that is confusing is the difference between PMCF and PMCF study. You can perform PMCF without actually performing a PMCF study. You create a PMCF plan and carry out the activities of the PMCF according to the plan and then based on your findings fill out the checklist to say a PMCF study is not required. If the auditor observes that you are actually performing PMCF and have determined that the PMCF study is not necessary, than that should be acceptable.
 

yodon

Staff member
Super Moderator
#5
That actually makes sense to me and seems to line up with the MDR. @Watchcat - the checklist is made from the list of questions found somewhere about considerations to be made for whether a study might be required. It just helps guide the collection of data to determine if one is needed and helps provide the rationale for whether one is needed or not.
 
#6
To echo Weeder, the distinction btw PMCF vs. a PMCF study comes through in Annex XIV, Part B 6.2.(a) vs. 6.2(b), in the notion of general methods vs. specific methods.

The PMCF plan shall include at least:
(a) the general methods and procedures of the PMCF to be applied, such as gathering of clinical experience gained, feedback from users, screening of scientific literature and of other sources of clinical data;
(b) the specific methods and procedures of PMCF to be applied, such as evaluation of suitable registers or PMCF studies;

(c) a rationale for the appropriateness of the methods and procedures referred to in points (a) and (b);

I'd interpret (a), general methods, to be blanket/ dragnet approaches, to look out for any signals that might emerge from PMCF-type data (including literature search, to OP's question). I'd interpret (b), specific methods, to be targeted approaches to get after particular areas of potential concern w/ the device (e.g., different patient or user sub-populations), or redress areas of weakness in the pre-market data.

Point (c) seems to call for making the case about whether or not a PMCF study (representing one type of a specific PMCF method that could be employed) is needed, probably based on whether there's anything specific that can't be adequately monitored through the general methods.
 

Weeder

Involved In Discussions
#7
mboynon has explained the PMCF concept very well. I am hoping this explanation will help a lot of people who are struggling with the issue. If only the regulatory agencies would take time to explain things in this simple straight forward way, we can all focus on making safe and effective devices rather than get mired in interpreting the requirements in twenty different ways.
 

Watchcat

Trusted Information Resource
#8
If only the regulatory agencies would take time to explain things in this simple straight forward way
IMO, it's the regulator's job to regulate, not to tutor medical device companies (or notified bodies) on how to do their jobs. If a company doesn't understand the regulations, it needs to hire someone who does and pay for this expertise itself, rather than expecting taxpayers to subsidize their business. Same thing goes for notified bodies who do not know how to evaluate a company's PMCF. In general, I think a medical device company should know better than the regulators how to do PMCF, including whether or not a PMCF is needed as part of the PMCF for a given device, and why.
 

Watchcat

Trusted Information Resource
#10
*someone* should clarify. The MDCG exists, at least in part, to give such guidance. I think it's pretty clear from the discussion that this topic could certainly use some guidance.
After mulling it over for several days, I think I'll let this one go, except for saying if "regulatory agencies" includes FDA, I'm opposed. I'll leave the EU to the EU.
 
Thread starter Similar threads Forum Replies Date
K MDCG 2020-7 PMCF Plan Similar Devices EU Medical Device Regulations 0
S PMS (Premarket Submission) and PMCF Plan EU Medical Device Regulations 5
M Clinical Evaluation Plan vs. PMCF Plan EU Medical Device Regulations 29
B PMCF study plan is same to clinical investigation plan? EU Medical Device Regulations 3
D Is PMCF really a continuous activity per Annex XIV,Part B? EU Medical Device Regulations 5
A CE Mark and PMCF study EU Medical Device Regulations 3
M MDR - Under what circumstances is a PMCF not required? EU Medical Device Regulations 1
A Post-market clinical followup studies (PMCF) EU Medical Device Regulations 16
R PMCF - centers/countries used CE Marking (Conformité Européene) / CB Scheme 0
M PMCF (Post Market Clinical Followup)/ PSUR template EU Medical Device Regulations 8
S PMCF (Post Market Clinical Followup): Rationale for Exemption - Software Medical Devices EU Medical Device Regulations 6
W Interesting Discussion PMCF (Post-Market Clinical Followup) vs PMCF studies EU Medical Device Regulations 36
S Do subjects pay for a medical implant in PMCF study? Quality Manager and Management Related Issues 3
C PMCF (Post Market Clinical Followup) Enrollment Sizes (Spinal Implants) EU Medical Device Regulations 5
Q Is there a way that I can combine two PMCF studies into one? EU Medical Device Regulations 4
B Inquiry about MEDDEV 2.12/2 rev2 - PMCF studies EU Medical Device Regulations 3
S Understanding PMS (Post Market Surveillance) and PMCF (Vigilance and PMCF) Quality Manager and Management Related Issues 1
L Residual risks which the PMCF study is based on ISO 14971 - Medical Device Risk Management 7
Jimmy123 IATF16949 Control Plan FMEA and Control Plans 1
Y SaMD Verification and Validation SOP and Plan IEC 62304 - Medical Device Software Life Cycle Processes 3
D Quality plan for moving locations ISO 13485:2016 - Medical Device Quality Management Systems 3
V ISO 10360-5: 2020 Gap analysis and Action plan Excel .xls Spreadsheet Templates and Tools 1
S Which Sampling Plan(s) Should I Use? Inspection, Prints (Drawings), Testing, Sampling and Related Topics 7
A Prototype control plan FMEA and Control Plans 2
S ISO9001:2015 Implementation / update plan template ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 2
K Do I need a "State of the art" plan? CE Marking (Conformité Européene) / CB Scheme 1
S Which department should prepare the control plan? could you show me a standard regarding to this matter. FMEA and Control Plans 17
G Control Plan & PFMEA Review Procedure? FMEA and Control Plans 1
L Sampling Plan Risks AQL - Acceptable Quality Level 6
Felony Melony Project Milestone Plan-Development to Mass Production APQP and PPAP 2
A Sampling plan for in-process QC (medical devices) Inspection, Prints (Drawings), Testing, Sampling and Related Topics 13
Q Contingency plan - IATF Sanctioned Interpretation 17 IATF 16949 - Automotive Quality Systems Standard 4
M Does the ISO 9001:2015 standard require a disaster recovery plan or emergency response plan ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 16
D Continuous Improvement Plan - Plastic injection molding IATF 16949 - Automotive Quality Systems Standard 1
M IVDR and Performance Evaluation Plan CE Marking (Conformité Européene) / CB Scheme 2
A The requirement of the PMS plan--suitable indicators and threshold values EU Medical Device Regulations 0
W LTPD, AQL, Ppk and Cpk validation sampling plan table Inspection, Prints (Drawings), Testing, Sampling and Related Topics 0
E BCP (Business Continuity Plan) Call Tree Business Continuity & Resiliency Planning (BCRP) 13
P IATF 16949 requirement - error-proofing in control plan IATF 16949 - Automotive Quality Systems Standard 3
B Biological evaluation plan and report Other Medical Device Related Standards 5
B Sterilization Validation Plan Other Medical Device Related Standards 3
earl62 What is the best way to control special characteristics in Control plan? Is it Mandatory to have SPC for IATF 16949? IATF 16949 - Automotive Quality Systems Standard 12
R Electrical contractor Project Quality Management Plan Quality Manager and Management Related Issues 1
M Clinical Development Plan - Advice Requested EU Medical Device Regulations 11
I Control Plan (Product/Process specification/ Tolerance) acceptance FMEA and Control Plans 27
J Control Plan use on the manufacturing floor FMEA and Control Plans 4
E Change in control plan - Do I have to do sampling? IATF 16949 - Automotive Quality Systems Standard 1
S Is using ANSI/ASQ Z1.4-2008 the correct sampling plan to determine Pass/Fail of Apparel measurements? AQL - Acceptable Quality Level 4
D All Dimensions listed on control plan FMEA and Control Plans 10
DuncanGibbons Resources for aiding in procedure, work instruction and manufacturing plan development and management AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 0

Similar threads

Top Bottom